Page last updated: 2024-08-25

perfluorooctane sulfonic acid and Atrophy

perfluorooctane sulfonic acid has been researched along with Atrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abedi-Valugerdi, M; Bogdanska, J; Butenhoff, JL; Chang, SC; DePierre, JW; Ehresman, DJ; Nelson, BD; Qazi, MR; Xia, Z1

Other Studies

1 other study(ies) available for perfluorooctane sulfonic acid and Atrophy

ArticleYear
The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARa
    Toxicology, 2009, Jun-16, Volume: 260, Issue:1-3

    Topics: Alkanesulfonic Acids; Animals; Atrophy; B-Lymphocytes; Body Weight; Caprylates; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Flow Cytometry; Fluorocarbons; Immunophenotyping; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Organ Size; PPAR alpha; Spleen; T-Lymphocytes; Thymus Gland

2009